KR20170101414A - Composition for skin-whitening and improving skin conditions containing fermented extracts of schizandra chinensis as active ingredient - Google Patents
Composition for skin-whitening and improving skin conditions containing fermented extracts of schizandra chinensis as active ingredient Download PDFInfo
- Publication number
- KR20170101414A KR20170101414A KR1020160023893A KR20160023893A KR20170101414A KR 20170101414 A KR20170101414 A KR 20170101414A KR 1020160023893 A KR1020160023893 A KR 1020160023893A KR 20160023893 A KR20160023893 A KR 20160023893A KR 20170101414 A KR20170101414 A KR 20170101414A
- Authority
- KR
- South Korea
- Prior art keywords
- skin
- omija
- extract
- improvement
- whitening
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Dermatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a cosmetic composition for whitening and improving skin comprising an omija fermented extract as an active ingredient.
Description
The present invention relates to a cosmetic composition for whitening and skin improvement comprising an extract of Omija fermented extract as an active ingredient.
In addition to rapid industrialization, the generation of strong oxidizing substances such as active oxygen species due to air pollution and the increase of UV amount due to ozone layer destruction cause skin aging and pigmentation in humans. Various antioxidants such as vitamin C, tocopherol and coenzyme Q10 have been used for the production of cosmetics for the purpose of protecting the skin from these various oxidizing substances. Recently, it has been found that various physiological active substances such as whitening, anti-aging, anti-wrinkle and antioxidant exist in various plants including herbal medicines, and thus their extracts are widely used in the production of natural cosmetics or herbal cosmetics.
Schizandra chinensis is a fruit of Omija, a plant belonging to the Magnoliaceae family, and is used for food. Omija has long been known to have medicinal properties such as astringency, nourishment, gangjang, Jinhae medicine, gadam, hay poison, thirst, astringency,
Fermentation refers to the process by which microorganisms degrade organic matter using their own enzymes. It is known that raw materials after fermentation through microorganisms are at least two times to several tens of times more effective than before fermentation. Fermented metabolites contain various amino acids, organic acids and antioxidants that are good for the skin, promoting skin metabolism and making skin texture resilient and smooth. In addition, it has been reported that the fermentation process reduces the particle size, decomposes toxic substances such as heavy metals, so that it has good absorption rate and alleviates skin troubles and allergy side effects.
Studies have been actively conducted to improve skin conditions, but there is still a need for new methods for these. Accordingly, the present invention is intended to apply a new natural fermented extract to the above-mentioned necessity.
The present invention is to provide a cosmetic composition for whitening and skin improvement comprising an extract of fermented Omija as an active ingredient.
One embodiment of the present invention provides a cosmetic composition for whitening and skin improvement comprising an extract of Omija fermentation as an active ingredient.
As used in the present invention, "Omiza" refers to fruit of Omiza, a plant belonging to the Magnoliaceae family.
The "Omiza extract" used in the present invention can be prepared by mixing Omiza, which is crushed by an extraction method known in the art, into an extraction solvent and then extracting it. Wherein the extraction solvent is at least one aqueous solution selected from the group consisting of water, an anhydrous or a lower alcohol having 1 to 4 carbon atoms, acetone, ethyl acetate, butyl acetate, dichloromethane, chloroform, hexane and 1,3- , Preferably sterile water or 60% ethanol, but is not limited thereto. In addition, two or more different solvents may be mixed in the extraction solvent or sequentially used.
The "Omija fermented extract" used in the present invention is prepared by drying the Omija extract naturally or by using an apparatus, specifically a rotary vacuum concentrator and a freeze drier, and then drying the Omija extract in a solvent, , Preferably 1 to 10% by weight, and then inoculating and fermenting the fermentation microorganism.
The fermentation microorganism refers to fermentation microorganisms commonly used in the fermentation related industry, and specifically includes lactic acid bacteria, enzymes, and the like, but is not limited thereto. Preferably, the fermentation microorganism is Leuconostoc mesenteroides , Weissella koreensis or Lactococcus lactis .
According to one embodiment of the present invention, the Omija fermented extract may contain gomisin N. (C 23 H 28 O 6 , molecular weight: 400.47), sizandrine A (C 24 H 32 O 7 , molecular weight: 432.51), hyperinsin A (C 23 H 28 O 7 , molecular weight : 416.46) and the like are separable from the omiza are known in the art. In the present invention, it was confirmed that the content of hypericin N was increased by 125% to 175% compared to that before fermentation by fermenting Omiza extract.
According to one embodiment of the present invention, the fermentation extract may be contained in an amount of 0.1 to 10% by weight, preferably 2 to 5% by weight, more preferably 3% by weight based on the total weight of the composition.
According to one embodiment of the present invention, the skin improvement is characterized in that the skin improvement is selected from the group consisting of antioxidant, melanocyte growth inhibition, melanin formation inhibition, inhibition of tyrosinase activity, inhibition of melanin formation related gene expression, dermal cell growth promotion, collagen increase, collagenase degradation, It is composed of growth promotion, inflammation suppression, skin hydration control, skin tone improvement, reduction of pigmentation, improvement of skin yellow tone, improvement of skin wrinkles, increase of dermis intimacy, improvement of skin elasticity, restoration of skin barrier, And the like.
Another embodiment of the present invention provides a cosmetic comprising the cosmetic composition for skin improvement.
The cosmetic may have formulations of ointments, solutions, suspensions, emulsions, pastes, gels, creams, lotions, serums, powders, soaps, surfactant-containing cleansing, oils, powder foundations, emulsion foundations, wax foundations and sprays , Preferably a formulation of a skin toner, a water cream or a cream, but is not limited thereto.
The present invention provides a new application for whitening and skin improvement of a composition containing an omija fermented extract containing hyperinsin N as an active ingredient. The fermented extract of the present invention is useful as an antioxidant, a melanin cell growth inhibitor, a melanin inhibitor, a tyrosinase inhibitor, a melanogenesis-related gene expression inhibitor, a dermal cell growth promoter, Skin irritation improvement, skin barrier improvement, skin texture improvement, skin erythema reduction, and the like, as compared with the case of the present invention.
1 shows the cell activity of melanoma cells (B16F10) according to the concentrations of schizandrin A, gomisin A and hyperinsin N among the components of the extract of Omija of the present invention.
Fig. 2 shows melanin formation inhibitory ability against melanoma cells against sizandrin A, maxin A and hyperinic N among the components of the extract of Omija of the present invention.
FIG. 3 shows the inhibitory effect of melanoma cell tyrosinase activity on sizandrin A, hyperinsin A and hyperinsin N among the components of the extract of Omija of the present invention.
FIG. 4 shows the ability of melanoma cells to inhibit the expression of MITF, tyrosine, TYRP-1 and Dct mRNA in hypermucin N among the components of the extract of Omija of the present invention.
Fig. 5 shows the effect of decomposing the active oxygen of the omega-fermented extract, omija extract, alpha -tocopherol and BHT of the present invention.
6 shows the cell activity of melanoma cells according to the concentration of the Omija fermentation extract of the present invention.
Fig. 7 shows the ability of Melanoma cells to inhibit melanin formation in the extract of Omija fermentation of the present invention.
Fig. 8 shows the inhibitory effect of tyrosinase activity on Melanoma cell of the Omija fermentation extract of the present invention.
FIG. 9 shows the inhibitory effect on the expression of MITF, tyrosine, TYRP-1 and Dct mRNA in melanoma cells of the Omija fermentation extract of the present invention.
FIG. 10 shows the cell activity of human dermal fibroblasts (nHDF) according to the concentration of the Omija fermentation extract of the present invention.
Figs. 11 and 12 show changes in expression of COL1A1 and collagenase MMP1 in human dermal fibroblasts, respectively.
FIG. 13 shows the cell activity of mouse macrophages (RAW 264.7) according to the concentration of the extract of the present invention.
Fig. 14 shows the activity of luciferase in the immune cells according to the concentration of the fermented extract of Omija of the present invention.
FIG. 15 and FIG. 16 show changes in IL-1β and TNF-α gene expression according to the concentration of the fermented extract of Omija of the present invention, respectively.
17 to 27 are graphs showing changes in skin moisture content, skin oil content, skin tone improvement, pigmentation reduction, skin yellow tone improvement, skin wrinkle degree and the like of the subject according to the period of use of cream and toner containing the Omija fermented extract of the present invention , Dermal density, skin elasticity, transdermal water loss, skin texture improvement and skin erythema.
Hereinafter, the present invention will be described in more detail with reference to one or more embodiments. However, these embodiments are illustrative of one or more embodiments, and the scope of the present invention is not limited to these embodiments.
1. Preparation of sample
1.1. Preparation of Omija fermented extract
The Omija fermentation extract was obtained using an ethanol extraction method commonly used in the art. Specifically, 100 g of crushed omija was mixed with 1 L of 60% ethanol at a ratio of 10% by weight. The mixed raw materials were extracted by stirring at room temperature for 48 hours. The above Omiza extract was filtered through 250 mesh and 0.5 mu m filter paper to obtain a liquid extract. Extraction dried material was obtained from the filtered liquid extract using a rotary vacuum concentrator and a freeze dryer. The extract was diluted to 3% by weight with purified water, and then the microorganisms for fermentation Leuconostoc mesenteroides were inoculated and fermented under anaerobic conditions at 35 ℃ for 72 hours. The fermented extract was filtered through 500 mesh and 0.2 mu m filter paper to obtain a liquid fermentation extract. As a result of carrying out a related test example of the composition according to the present invention thus formed, it was confirmed that there is no abnormality in the skin stability.
1.2. Manufacture of skin toner
The composition of the ingredients for making a skin toner containing the composition of the present invention is shown in the following Table 1 and is prepared by the following procedure. The A phase (water phase) was completely dissolved at room temperature and the B phase (alcohol phase) was heated to 50 DEG C using a heater. The phase B was mixed with the phase A and solubilized at 1000 rpm for 10 minutes using a disperser. The mixture was cooled, filtered, and maintained at a pH of 5.2 to complete a skin toner. The Omija fermented extract was prepared by adding an amount of 3% by weight.
1.3. Manufacture of moisture cream
The composition of the composition for making the water cream containing the composition of the present invention is shown in Table 2 below. Concretely, the A phase was heated to 80 DEG C and stirred, and the B phase was heated to 80 DEG C to dissolve, and then the mixture was put into the phase A and emulsified at 2000 rpm for 10 minutes. The C phase was evenly dissolved, and the mixture was put into the phase A and emulsified at 2000 rpm for 10 minutes. The C phase was evenly mixed, and the mixture was put on the A + B phase at 80 ° C and neutralized at 2000 rpm for 5 minutes. The solution was cooled to 30 DEG C while stirring slowly, and adjusted to pH 6.15. The Omija fermented extract was prepared by adding an amount of 3% by weight.
1.4. Manufacture of cream
The constituents for preparing the cream containing the composition of the present invention are shown in Table 3 below. Concretely, the A phase was heated to 80 DEG C and stirred, and the B phase was heated to 80 DEG C to dissolve, and then the mixture was put into the phase A and emulsified at 2000 rpm for 10 minutes. The C phase was evenly mixed, and the mixture was put on the A + B phase at 80 ° C and neutralized at 2000 rpm for 5 minutes. Subsequently, the mixture was gradually cooled to 30 DEG C while being mixed and stirred, and adjusted to pH 6.23. The Omija fermented extract was prepared by adding an amount of 3% by weight.
2. Experimental methods and results
Example 1: Cytosan toxicity of melanoma cells to tyzandrin A, hyperinsin A and hyperinsin N
In order to confirm the whitening effect of the extract of Omija, it was observed that the growth of melanoma cells synthesizing melanin, which is a substance for determining skin color, was suppressed by sizzlin A, Respectively.
The single component of sizandrine A was purchased from Sigma-Aldrich, the single component of hypermucin A and hyperinsin N was purchased from Chemfaces, and the melanoma cell (B16F10) was purchased from ATCC. The cell culture medium was supplemented with 10% fetal bovine serum (FBS; Gibco), 10% penicillin (100 units / mL) and streptomycin (100 g / mL) in Dulbecco's modified Eagle's sediments (DMEM; Gibco) ) Was added and used. The cultivation was carried out under the conditions of 37 ° C, 95% humidity and 5% CO 2 incubator, and cells between 3 and 10 generations were used for the experiment. To examine the degree of cytotoxicity of melanoma cells, B16F10 cells treated with sizzindine A, hypermucin A, and hypermystin N, sizadrine A, hypermynx A and hypermysine N were added at respective concentrations Cells were cultured for 24 hours after treatment, and then viability was measured using MTT of cells.
As a result of the analysis, although the difference in the decrease width according to the treated substance was shown, the cell growth was decreased in a concentration-dependent manner after the treatment of sizzlin A, hyperminus A and hyperinsin N, compared with the control (no treatment group) 1).
Example 2. Sizandrin A, High superstition A and High superstition For N Melanoma Formation of melanin in cells Inhibition Confirm
In order to confirm the whitening effect of the extract of Omija, it was experimentally examined whether the formation of melanin, a substance for determining the color of skin, was inhibited by sizzlin A, hypermucin A and hypermisin N, which are components of Omija extract. Melanoma cells were cultured on a 60-mm plate for 24 hours, and the α-MSH and Omija extract components were treated at respective concentrations and then cultured for 48 hours in order to confirm the degree of change of melanin formation by the component of Omija extract.
Then, the cells were detached from each plate, and the cells were washed with PBS to remove the medium components and dissolved using 1N sodium hydroxide solution. Each cell lysate sample was measured at a wavelength of 450 nm using a plate reader.
As a result, inhibition of melanin formation was confirmed in the group treated with sizandrin A and hypericin N, compared with the negative control group (treated with? -MSH), and no change was observed in the
Example 3. Sizandrin A, High superstition A and High superstition For N Melanoma Intracellular Tyrosinase activation Inhibition Confirm
In order to confirm the whitening effect of the extract of Omija, the activity of tyrosinase, which plays an important role in the formation of melanin, was tested by inhibiting the action of tyrosinolin A, hyperinsin A and hyperinsin N, which are components of Omija extract. Melanoma cells were cultured on a 60 mm plate for 24 hours, and α-MSH and Omiza extract components were treated at respective concentrations and cultured for 48 hours in order to confirm the degree of change of tyrosinase activity by the component of Omija extract.
Then, each cell was detached and the cells were dissolved using a cell lysis buffer. Each cell lysate was mixed with 0.1M sodium phosphate buffer containing L-DOPA and tyrosinase substrate, and reacted at 37 ° C for 20 minutes. Each reaction was then measured at 450 nm using a plate reader.
As a result of the analysis, it was confirmed that the tyrosinase activity was inhibited in the group treated with sizandrin A and hypericin N, compared with the negative control group (treated with? -MSH), and no change was observed in the hypermynine A treated group See Table 6 and Fig. 3 below).
activation(%)
Example 4. High superstition For N Melanoma Intracellular MITF , Tyrosinase , TYRP -1 and Dct mRNA Expression Inhibition Confirm
In order to confirm the whitening effect of Omija extract, we examined whether the expression of mRNA related to whitening is inhibited by hypericin N, a component of Omija extract. In order to confirm the degree of mRNA expression change by the extract of Omija, melanoma cells were treated with hypericin N at respective concentrations and cultured for 24 hours.
Herein, quantitative real-time PCR (qRT-PCR), which is a method of continuously detecting a fluorescent substance by attaching a fluorescent substance to a DNA product amplified during a polymerase chain reaction (PCR) PCR). To quantitatively determine changes in MITF, tyrosinase, TYRP-1 and Dct gene expression by hypermucin N, SYBR Green I (Invitrogen) was used to confirm the results of the fluorescence values emitted by the PCR products Respectively. The reaction solution was prepared by mixing 0.2 μM primer, 50 mM KCl, 20 mM Tris / HCl pH 8.4, 0.8 mM dNTP, 0.5 U Extaq DNA polymerase, 3 mM MgCl 2 and 1 × green. The denaturation, annealing and polymerization were carried out at 94 ° C for 30 seconds, 58 ° C for 30 seconds, and 72 ° C for 30 seconds, respectively, after primary denaturation at 94 ° C for 3 minutes using Linegene K (BioER) 40 cycles and fluorescence intensity was measured after each cycle. PCR results were verified by melting curve for each result. The threshold cycle (Ct) value of each gene was normalized to the Ct value of β- actin, and the amount of change in the Ct value was compared and analyzed. The Ct value was the number of cycles when the amount of fluorescence generated by the PCR product (the number of amplified PCR products) reached a constant reference value above the basal value, and the amount of gene expression was confirmed through the Ct value. Table 7 shows the respective genes used in the experiment.
As a result, the amount of MITF, tyrosinase, TYRP-1, and Dct mRNA expression decreased in a dose-dependent manner after treatment with high myosin N, a component of Omija extract, compared to the control (untreated group) (See Table 8 and Fig. 4 below).
Expression (%)
Expression (%)
Expression (%)
Expression (%)
Example 5 Confirmation of Effect of Oxygen Fermentation Extract on Active Oxygenation
In order to confirm the effect of improving the skin cosmetics by the extract of Omija fermentation, we investigated whether the active oxygen species, which plays a major role in skin aging, are removed by the Omija fermentation extract.
A method for measuring free radical scavenging activity using 1,1-diphenyl-2-picryl hydrazyl (DPPH), a free radical, Was used. 4 mL of methanol was added to the test tube, and the Omija fermented extract was added to each concentration. Then, 1 mL of 0.15 mM DPPH solution was added, reacted at room temperature for 30 minutes, and absorbance was measured at 520 nm. Initial (Ai) and blank (Ab) without substrate and DPPH were measured, and mutagenic extracts, α-tocopherol and BHT were compared in positive control.
As a result of the analysis, the Omija fermented extract according to the present invention exhibited a higher activity of oxygen scavenging ability at a lower concentration than that of the positive control, Omiza extract,? -Tocopherol and BHT (see Table 9 and Fig. 5 below) And it was confirmed that it is effective in improving the beauty of the skin.
Example 6. Confirmation of cytotoxicity of Melanoma cells on Omija fermented extract
In order to confirm the whitening effect of Omija fermentation extract, we examined whether melanoma cell growth which synthesizes melanin, which is a substance for determining skin color, is inhibited by Omija fermentation extract.
Experiments were carried out in the same manner as described in Example 1, except that the omija fermented extract was treated in place of the omija fermented extract components (sizandrin A, high mucin A and hypermystin N). As a positive control group, the group treated with Omija extract was used.
As a result of the analysis, the cell growth was decreased in a concentration-dependent manner after the treatment of the Omija fermentation extract (see Table 10 and FIG. 6), as compared with the control (no treatment group).
Survival after treatment (%)
Survival after treatment (%)
Example 7. Confirmation of inhibition of melanin formation in Melanoma cells against Omija fermented extract
In order to confirm the whitening effect of Omija fermentation extract, we examined whether melanin formation, which is a substance for determining skin color, is inhibited by Omija fermentation extract. Experiments were carried out in the same manner as described in Example 2, except that the omija fermented extract was treated in place of the omija fermented extract component. As a positive control group, the group treated with Omija extract was used.
As a result of the analysis, melanin formation was inhibited after treatment of the Omija fermentation extract (see Table 11 and Fig. 7 below), as compared with the control group (treated with? -MSH).
Example 8. Confirmation of inhibitory activity of melanoma intracellular tyrosinase activity on Omija fermented extract
In order to confirm the whitening effect of Omija fermentation extract, the activity of tyrosinase, which plays an important role in the formation of melanin, was inhibited by the Omija fermentation extract. The experiment was carried out in the same manner as described in Example 3, except that the Omija fermented extract was treated in place of the Omija fermented extract component. As a positive control group, the group treated with Omija extract was used.
As a result of analysis, tyrosinase activity was inhibited after treatment of Omija fermented extract, as compared with the control group (treated with? -MSH) (see Table 12 and FIG. 8).
activation(%)
Example 9. For Omija fermented extract Melanoma Intracellular MITF , Tyrosinase , TYRP -1 and Dct mRNA Confirm expression inhibition
In order to confirm the whitening effect of Omija fermentation extract, we examined whether Omija fermentation extract inhibited the expression of mRNAs related to whitening. Experiments were carried out in the same manner as described in Example 4, except that the Omija fermented extract was treated in place of hypermucin N. [
As a result, the amount of MITF, tyrosinase, TYRP-1 and Dct mRNA expression was decreased in a concentration-dependent manner after treatment with Omija fermentation extract, as compared with the control (untreated group) And 14, and Fig. 9).
Expression (%)
Expression (%)
Expression (%)
Expression (%)
Expression (%)
Expression (%)
Expression (%)
Expression (%)
Example 10 Confirmation of Growth Promoting Effect of Human Dermal Fibroblast by Omija Fermented Extract
In order to confirm the effect of improvement of skin cosmetic effect by the extract of Omija fermentation, it was experimentally examined whether the fibroblast growth which synthesizes collagen which is a constituent of the dermis is promoted by the Omija fermentation extract.
Experiments were carried out in the same manner as described in Example 1, except that human dermal fibroblast (nHDF) was used instead of Melanoma cells and Omija fermented extract was used instead of Omija fermented extract. Human dermal fibroblast (nHDF) was purchased from Lonza.
As a result, the cell growth was increased in a concentration-dependent manner after the treatment of Omija fermented extract (see Tables 15 and 16, and FIG. 10, below), compared to the control group (untreated group).
Example 11 Confirmation of Increased Col1A1 Expression and MMP1 Expression by Omija Fermented Extract
In order to confirm the effect of improving the skin-cosmetic effect of the omelet fermentation extract, the expression of COL1A1, one of typical collagen expressed by human dermal fibroblasts, and MMP1, a collagenase, was measured. In order to confirm the degree of change of collagen expression by the Omija fermentation extract, Omija fermented extract was treated with human dermal fibroblast at various concentrations and then cultured for 24 hours.
Herein, quantitative real-time PCR (qRT-PCR), which is a method of continuously detecting a fluorescent substance by attaching a fluorescent substance to a DNA product amplified during a polymerase chain reaction (PCR) PCR). SYBR Green I (Invitrogen) was used to quantitatively determine the expression of COL1A1 and MMP1 gene expression by the extracts of Omija fermentation, using the fluorescence values emitted by the PCR products. The reaction solution was prepared by mixing 0.2 μM primer, 50 mM KCl, 20 mM Tris / HCl pH 8.4, 0.8 mM dNTP, 0.5 U Extaq DNA polymerase, 3 mM MgCl 2 and 1 × green. The denaturation, annealing and polymerization were carried out at 94 ° C for 30 seconds, 58 ° C for 30 seconds, and 72 ° C for 30 seconds, respectively, after primary denaturation at 94 ° C for 3 minutes using Linegene K (BioER) 40 cycles and fluorescence intensity was measured after each cycle. PCR results were verified by melting curve for each result. The threshold cycle (Ct) value of each gene was normalized to the Ct value of β- actin, and the amount of change in the Ct value was compared and analyzed. The Ct value was the number of cycles when the amount of fluorescence generated by the PCR product (the number of amplified PCR products) reached a constant reference value above the basal value, and the amount of gene expression was confirmed through the Ct value. Table 17 shows the respective genes used in the experiment.
As a result, the expression of Col1A1 mRNA was increased in a concentration-dependent manner after treatment with the extract of Omija fermentation extract (see Table 18 and FIG. 11). In addition, the expression of MMP1 mRNA was decreased in a concentration-dependent manner after the treatment of the Omija fermentation extract (see Table 19 and Fig. 12).
Example 12. Confirmation of the inhibitory effect of Omija fermentation extract on the growth of immune cells
In order to confirm the effect of improving the skin cosmetic effect by the extract of Omija fermentation, the growth of mouse macrophage (RAW 264.7), which acts on inflammation and erythema of the skin, was inhibited by the Omija fermentation extract.
Mouse immune cells were purchased from Korean Cell Line Bank (KCTC). Cell culture medium was prepared by adding 10% FBS (Gibco), 10% penicillin (100 units / mL) and streptomycin (100 g / mL) to DMEM (Gibco). The cultivation was carried out at 37 ° C, 95% humidity, 5% CO 2 incubator conditions, and cells between 3 and 10 generations were used for the experiment. In order to examine the degree of cytotoxicity of the RAW 264.7 cells treated with Omija fermentation extract, the cells were cultured for 24 hours after each treatment with Omija fermented extract, Were measured.
As a result of analysis, cell growth was decreased in a concentration-dependent manner after treatment of Omija fermentation extract (see Tables 20 and 21 and 13 below), as compared with the control (no treatment group).
Example 13 Confirmation of NF-kB Transcription Inhibitory Effect by Omija Fermented Extract
In order to confirm the improvement of skin cosmetic effect by Omija fermentation extract, we examined whether the transcription ability of NF-kB, which is a transcription factor of cytokine which plays an important role in immune response, is inhibited by Omija fermentation extract.
NF-kB reporter assay was performed to determine the degree of suppression of NF-kB transcriptional activity when Omija fermented extract was treated with immune cells. The promoter region of the gene known to be transcribed by NF-kB was cloned into a vector containing the luciferase gene and inserted into the immune cells. After NF-kB transcription was activated by LPS inducing NF-kB transcription, Omija fermented extract was treated with each concentration and luciferase activity was measured. The luciferase activity is determined by the presence of the IgG kappa NF- kappa B region (SEQ ID NO: 5-GGGGACTTTCC-3) oligonucleotides upstream of the minimal IL-8 promoter (positions 67 to +44), the NF- (Gibco-BRL), and the gene was inserted into the immune cells according to the reagent manual. The lipofectamine plus (Gibco-BRL) Immunosuppressed cells were treated with LPS to activate the transcriptional activity of NF-kB, and the Omija fermented extract was treated at 0, 1, 10, and 100 mg / L, and cultured for 24 hours. The cultured immune cells were directly added with 0.1 mL dissolution buffer (0.1 M HEPES, pH 7.6, 1% Triton-X, 1 mM DTT, and 2 mM EDTA) at the time of collection to collect cell lysates, The cells were centrifuged at rpm to obtain cell proteins. Protein concentration was measured using a Bradford assay (Bio-Rad Laboratories), and then 20 μg of protein was added to a luciferase assay mixture (25 mM glycylglycine, 15 mM MgSO 4 , 1 mg / mL BSA, ATP and 1 mM D-luciferin (Analytical Luminescence Laboratory), and the luminescence was measured three times repeatedly for 20 seconds using Monolight 2010 (Analytical Luminescence Laboratory) to obtain an average value.
As a result of the analysis, the transactivity of NF-κB increased by LPS after the treatment of Omija fermented extract was decreased in a concentration-dependent manner (see Table 22 and FIG. 14).
Example 14 Confirmation of Inhibitory Effect on Inflammatory Cytokine Synthesis by Omija Fermented Extract
In order to confirm the skin cosmetic improvement effect of Omija fermentation extract, it was confirmed that the synthesis of the inflammatory cytokine inducing the immune response was inhibited by the Omija fermentation extract.
To confirm the degree of expression of inflammatory cytokine by Omija fermentation extract, Ominea fermented extract was treated with LPS-treated immune cells at various concentrations and cultured for 24 hours. The gene expression changes were then measured by qRT-PCR. SYBR Green I (Invitrogen) was used to quantitatively determine changes in IL-1β and TNF-α gene expression by Omija fermentation extract, using the fluorescence values emitted by the PCR products. The reaction solution was prepared by mixing 0.2 μM primer, 50 mM KCl, 20 mM Tris / HCl pH 8.4, 0.8 mM dNTP, 0.5 U Extaq DNA polymerase, 3 mM MgCl 2 and 1 × green. The denaturation, annealing and polymerization were carried out at 94 ° C for 30 seconds, 60 ° C for 30 seconds, and 72 ° C for 30 seconds, respectively, after primary denaturation at 94 ° C for 3 minutes using Linegene K (BioER) 40 cycles and fluorescence intensity was measured after each cycle. PCR results were verified by melting curve for each result. The Ct value of each gene was normalized to the Ct value of β - actin, and the change of the Ct value was compared and analyzed. The Ct value was the number of cycles when the amount of fluorescence generated by the PCR product (the number of amplified PCR products) reached a constant reference value above the basal value, and the amount of gene expression was confirmed through the Ct value. Primers of each gene used in the experiment are shown in Table 23 below. L-NG-monomethyl arginine and acetate salt (L-NG-Monomethylarginine, Acetate Salt; L-NMMA) were used as the positive control.
As a result of the analysis, the expression of IL-1β mRNA increased by LPS in a concentration-dependent manner after the treatment of Omija fermentation extract was decreased as compared with the LPS-treated group (see Table 24 and FIG. In addition, the expression of TNF-α mRNA increased by LPS in a concentration-dependent manner after the treatment of Omija fermentation extract was decreased as compared with the LPS-treated group (see Table 25 and FIG. 16).
(Drainage)
(Drainage)
Example 15. Confirmation of changes in the skin water content index by the fermented extract of Omija
In order to confirm the improvement effect of the cosmetic fermentation by Omija fermentation extract, the skin water content was analyzed using a corneometer and a sebumeter.
First, in order to examine the effect of the extract of fermentation of Omija on the improvement of skin oil, 30 adult women over 30 years old were selected and the cream and toner were used. Cream and toner were used for the control, the positive control and the experimental group for 2 weeks and 4 weeks, respectively, and skin moisture index was measured according to the instrument manual using a moisture analyzer (MPA5, Courage-Khazaka Electronic GmbH). Using a moisture analyzer, the same test person measured the right ball portion of the subject to be measured three times in succession. Skin oil index was measured according to the instrument manual using a sebum analyzer (MPA5, Courage-Khazaka Electronic GmbH). Using the sebum analyzer, the same person in charge of the test measured the area of the forehead which is the measurement site of the subject.
As a result of analysis, the skin moisture was increased in a time-dependent manner after treatment with the extract of Omija fermentation extract (see Table 26 and Fig. 17 below), as compared with the control (no treatment group). In addition, in the case of oil, the skin moisture was increased in a concentration-dependent manner after treatment of the Omija fermentation extract (see Table 27 and Fig. 18), as compared with the control (no treatment group).
Example 16 Confirmation of Skin Tone Improvement Effect by Omija Fermented Extract
In order to confirm the effect of improving the skin tone by the Omija fermentation extract, skin tones were analyzed using a spectrophotometer.
First, 30 adult women aged 30 years or older were selected to use the cream and toner prepared in order to examine the effect of the extract of fermentation of Omija on skin tone improvement. The control, positive control, and experimental groups were allowed to use cream and toner for two and four weeks, respectively, followed by spectrophotometer (Spectrophotometer CR-2600D, Konica Minolta) according to the instrument manual. The same test person measured the right side of the subject's right side of the ball three times in succession, and the mean value was calculated and used for the analysis. The values measured in the spectrophotometer are L *, a * and b *, and the skin tone is bright as the L * value increases to a value indicating the skin tone.
As a result of analysis, skin tones increased in time-dependent manner after treatment of Omija fermented extract, as compared with the control (no treatment group) (see Table 28 and Fig.
Example 17. Confirmation of Improvement of Pigmentation by Omija Fermented Extract
In order to confirm the improvement effect of skin cosmetic effect by the extract of fermented Omija, the effect of improving pigment deposition was confirmed.
First, in order to confirm the effect of Omija fermentation extract on improvement of pigmentation, 30 adult women over 30 years old were selected and cream and toner were used. The control, positive control and experimental groups were allowed to use cream and toner for 2 and 4 weeks, respectively, and then measured according to the instrument manual using ANTERA 3D (Miravex). The same examiner used the left ball area three times in a row for analysis.
As a result of analysis, the pigmented area decreased in a time-dependent manner after treatment of the Omija fermented extract, as compared to the control (no treatment) (see Table 29 and Fig. 20 below).
Example 18. Confirmation of improving effect of skin yellow tone by fermented extract of Omija
In order to confirm the improvement effect of skin yellow tones caused by the extract of Omija fermentation, skin tone uniformity was analyzed.
First, in order to examine the effect of the Omija fermented extract on the improvement of skin yellow tone, 30 adult women over 30 years old were selected and cream and toner were used. The control, positive control, and experimental groups were allowed to use cream and toner for two and four weeks, respectively, followed by spectrophotometer (Spectrophotometer CR-2600D, Konica Minolta) according to the instrument manual. The same test person measured the right side of the subject's right side of the ball three times in succession, and the mean value was calculated and used for the analysis. The values measured in the spectrophotometer are L *, a * and b *, and as the b * value decreases to a value indicative of skin yellow tones, the skin yellow tones are less noticeable
As a result of analysis, skin yellow tones decreased in a time-dependent manner after treatment with Omija fermentation extract (see Table 30 and Fig. 21 below), as compared with the control (no treatment group).
Example 19. Confirmation of the effect of improving the wrinkles of the skin by the fermented extract of Omija
In order to confirm the effect of improving the wrinkles of the skin caused by the extract of Omija fermentation, skin wrinkles were analyzed using a skin analyzer.
First, in order to confirm the effect of the extract of fermentation of Omija on the improvement of wrinkles of skin, 30 adult women over 30 years old were selected and cream and toner were used. Cream and toner were used for 2 weeks and 4 weeks for the control, the positive control and the experimental group, respectively. The degree of facial wrinkling was measured using PRIMOS Lite (field of view 18 × 13-simple, flexible 3D measuring, GFMesstechnik GmbH) Measured according to the instrument manual. Using the PRIMOS light, the same test person fixes the face of the subject on a specially prepared PRIMOS facial fixation kit and adjusts the tip of the eye, the measurement site, to match the focus pattern of the PRIMOS light Respectively.
As a result of analysis, the wrinkles of the tail of the tail were decreased in a time-dependent manner after the treatment of the Omija fermentation extract (see Table 31 and Fig. 22), as compared with the control (no treatment group).
Example 20 Confirmation of Skin Thickness Improvement Effect by Omija Fermented Extract
The increase of the proliferation of dermal fibroblast and the increase of collagen expression by the fermented extract of Omija were confirmed. Thus, it was analyzed whether the thickness of the dermal layer was increased by the generated collagen, and the effect of improving the skin thickness by the Omija fermentation extract was confirmed.
First, 30 adult women aged 30 years or older were selected to use the cream and toner prepared in order to examine the effect of the extract of fermented Omija on skin thickness. The control, positive control and experimental groups were allowed to use cream and toner for 2 and 4 weeks, respectively, and then measured according to the instrument manual using a DUB-skin scanner (tpm taberna pro medicum). A DUB-skin scanner was applied with a gel for ultrasound examination and the probe was placed at right angles to the skin, and then the same test person was measured with the same pressure on the right side of the subject's right eye.
As a result of analysis, the thickness of the skin was increased in a time-dependent manner after treatment of the Omija fermented extract, as compared with the control (no treatment group) (see Table 32 and FIG.
Example 21 Confirmation of Skin Elasticity Improvement Effect by Omija Fermented Extract
The effect of improving the skin elasticity was confirmed in order to confirm the skin cosmetic improvement effect by the extract of the fermented Omija extract. In order to confirm the effect of Omija fermented extract on skin thickness, 30 adult women over 30 years old were selected and cream and toner were used. After using cream and toner for 2 weeks and 4 weeks for control, positive control and experimental group respectively, the degree of change of skin elasticity was measured with DermaLab USB elasticity probe. The DermaLab USB elastic probe shows the skin change and resilience with time of inhalation and inhalation time. The same test person measured the probe three times after fixation to the left ball with tape.
As a result of analysis, elasticity of skin increased time-dependently after treatment of Omija fermentation extract (see Table 33 and Fig. 24 below), as compared with the control (untreated group).
Example 22 Confirmation of Skin Barrier Improvement by Omija Fermented Extract
The effect of improving the skin barrier was confirmed in order to confirm the improvement effect of the skin cosmetic effect by the omija fermentation extract.
First, 30 adult women aged 30 years or older were selected to use the cream and the toner in order to confirm the effect of the extract of fermentation of Omija on skin barrier improvement. Cream and toner were used for 2 weeks and 4 weeks for the control, the positive control and the experimental group, respectively. Then, the TEWL (TransEpidermal Water Loss) was measured using a DermaLab USB TEWL probe (Cortex Technology, Inc.) It was measured according to the manual of the apparatus.
As a result of analysis, the amount of transdermal water loss was reduced in a time-dependent manner after treatment with the extract of Omija fermentation extract (see Table 34 and FIG. 25), as compared with the control (no treatment group).
Example 23. Confirmation of improvement of skin texture by fermented extract of Omija
In order to confirm the effect of improvement of skin cosmetic effect by the extract of Omija fermentation, the effect of improving skin texture was confirmed.
First, in order to examine the effect of the extract of fermented Omija extract on the improvement of skin texture, 30 adult women over 30 years old were selected and the cream and toner were used. After 2 and 4 weeks of cream and toner were applied to the control, positive control, and experimental groups respectively, skin texture was measured according to the instrument manual using PRIMOS light (field of
As a result of analysis, the depth of wrinkles formed on the skin to determine skin texture decreased in a time-dependent manner after the treatment of Omija fermentation extract (see Table 35 and Fig. 26 below), as compared with the control (untreated group).
Example 24. Confirmation of the improvement effect of erythema vermicular extract
The inhibition of the proliferation of the immune cells and the decrease of the expression of the inflammatory cytokines by the fermented extract of Omija were confirmed through Examples 12, 13 and 14. Therefore, it was analyzed whether erythema was reduced by the reduced cytokine, and the erythema improvement effect of the Omija fermentation extract was confirmed.
First, in order to confirm the effect of Omija fermented extract on the improvement of erythema, 30 adult women over 30 years old were selected and the cream and toner were used. The control, positive control, and experimental groups were allowed to use cream and toner for two and four weeks, respectively, followed by spectrophotometer (Spectrophotometer CR-2600D, Konica Minolta) according to the instrument manual. The same test person measured the right side of the subject's right side of the ball three times in succession, and the mean value was calculated and used for the analysis. The values measured in the spectrophotometer are L *, a *, and b *, and the red value indicates a lot of red as the value of a * increases to a value indicating erythema.
As a result of analysis, erythema decreased in a time-dependent manner after treatment of Omija fermented extract, as compared with the control (no treatment group) (see Table 36 and Fig. 27 below).
The present invention has been described with reference to the preferred embodiments. It will be understood by those skilled in the art that various changes in form and details may be made therein without departing from the spirit and scope of the invention as defined by the appended claims. Therefore, the disclosed embodiments should be considered in an illustrative rather than a restrictive sense. The scope of the present invention is defined by the appended claims rather than the foregoing description, and all changes or modifications derived from the meaning and scope of the claims and equivalents thereof are included in the scope of the present invention. .
Claims (6)
Wherein the Omija fermented extract comprises gomisin N. 5. A cosmetic composition for improving whitening and skin.
The cosmetic composition for improving whitening and skin, wherein the Omija fermented extract is a fermented extract prepared by diluting a dried product of an extract obtained from Omija in a solvent, inoculating the microorganism for fermentation, and fermenting the fermented extract.
Wherein the fermentation extract is contained in an amount of 0.1 to 10% by weight based on the total weight of the composition.
The skin improvement may be selected from the group consisting of antioxidant, inhibition of melanin cell growth, inhibition of melanin formation, inhibition of tyrosinase activity, suppression of gene expression related to melanin formation, promotion of dermal cell growth, increase of collagen, reduction of collagenase, promotion of immune cell growth, , Skin tone improvement, pigmentation reduction, skin yellow tone improvement, skin wrinkle improvement, dermis intimacy increase, skin elasticity improvement, skin barrier recovery, skin texture improvement and skin erythema reduction A cosmetic composition for whitening and improving skin.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160023893A KR101793703B1 (en) | 2016-02-29 | 2016-02-29 | Composition for skin-whitening and improving skin conditions containing fermented extracts of schizandra chinensis as active ingredient |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160023893A KR101793703B1 (en) | 2016-02-29 | 2016-02-29 | Composition for skin-whitening and improving skin conditions containing fermented extracts of schizandra chinensis as active ingredient |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20170101414A true KR20170101414A (en) | 2017-09-06 |
KR101793703B1 KR101793703B1 (en) | 2017-11-03 |
Family
ID=59925437
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020160023893A KR101793703B1 (en) | 2016-02-29 | 2016-02-29 | Composition for skin-whitening and improving skin conditions containing fermented extracts of schizandra chinensis as active ingredient |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101793703B1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101974868B1 (en) * | 2017-11-20 | 2019-05-03 | 박병희 | Preparing method for mixed fermentation composition of rice bran and schisandra berry and a female cleansing composition containg the same as an active ingredient |
KR20200085114A (en) * | 2019-01-04 | 2020-07-14 | 박병희 | A cosmetic composition for improving skin barrier function power containing an extract of fermented omija as an effective ingredient |
KR20200085126A (en) * | 2019-01-04 | 2020-07-14 | 박병희 | A cosmetic composition for preventing or improving skin wrinkles containing an extract of fermented omija as an effective ingredient |
KR20200121635A (en) | 2019-04-16 | 2020-10-26 | 계명대학교 산학협력단 | Pharmaceutical Composition Comprising Gomisin M2 for Preventing or Treating Allergic Disease |
CN114948823A (en) * | 2022-07-18 | 2022-08-30 | 高州市人民医院 | Cleansing oil, preparation method and application thereof |
-
2016
- 2016-02-29 KR KR1020160023893A patent/KR101793703B1/en active IP Right Grant
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101974868B1 (en) * | 2017-11-20 | 2019-05-03 | 박병희 | Preparing method for mixed fermentation composition of rice bran and schisandra berry and a female cleansing composition containg the same as an active ingredient |
KR20200085114A (en) * | 2019-01-04 | 2020-07-14 | 박병희 | A cosmetic composition for improving skin barrier function power containing an extract of fermented omija as an effective ingredient |
KR20200085126A (en) * | 2019-01-04 | 2020-07-14 | 박병희 | A cosmetic composition for preventing or improving skin wrinkles containing an extract of fermented omija as an effective ingredient |
KR20200121635A (en) | 2019-04-16 | 2020-10-26 | 계명대학교 산학협력단 | Pharmaceutical Composition Comprising Gomisin M2 for Preventing or Treating Allergic Disease |
CN114948823A (en) * | 2022-07-18 | 2022-08-30 | 高州市人民医院 | Cleansing oil, preparation method and application thereof |
Also Published As
Publication number | Publication date |
---|---|
KR101793703B1 (en) | 2017-11-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101793703B1 (en) | Composition for skin-whitening and improving skin conditions containing fermented extracts of schizandra chinensis as active ingredient | |
WO2009145419A2 (en) | Composition comprising vegetable peptone for promoting stem cell proliferation | |
KR101638551B1 (en) | Improving composition for skin-antiwinkle and skin-whitening, Preparing method thereof, and Skin-externals containing the same | |
CN115554226B (en) | Multi-strain fermentation filtrate and preparation method and application thereof | |
EP2953611A1 (en) | Use of a composition comprising avocado perseose in the protection of epidermal stem cells | |
CN108778241B (en) | Cosmetic or skin care composition and use thereof | |
KR101784201B1 (en) | Composition for improving skin conditions containing fermented extracts of artemisia annua as active ingredient | |
KR101723944B1 (en) | Composition for improving skin conditions and preventing or treating proliferative skin diseases containing mixed fermented extracts of live-forever and swiftlet's nest as active ingredient | |
KR101754218B1 (en) | Composition for improving skin conditions and preventing or treating proliferative skin diseases containing fermented extracts of lactic acid bacteria complex and portulaca oleracea as active ingredient | |
KR100994987B1 (en) | Cosmetic composition with the calming effect for skins | |
KR101648148B1 (en) | Cosmetic composition containing fermented graviola for improving anti-wrinkle and method of preparing the same | |
Fares et al. | Green tannins/avocado oil composites; suncare and skincare materials | |
KR101739422B1 (en) | Composition for improving skin conditions and preventing or treating proliferative skin diseases containing centella asiatica extracts originated from plant factory | |
KR101841118B1 (en) | Composition for skin external application comprising extract of scenedesmus sp. | |
CN113101256A (en) | Anti-aging repair nanoemulsion and application thereof | |
KR101698410B1 (en) | Composition for improving skin conditions and preventing or treating proliferative skin diseases containing fermented extracts of sedum as active ingredient | |
JP2011162457A (en) | Plant fermentation extract, method for producing the same and cosmetic | |
KR101775122B1 (en) | Composition for improving skin conditions and preventing or treating proliferative skin diseases containing fermentation broth of yeast lysate mixture | |
KR20180020574A (en) | Cosmetic compositon for removing heavy metal or fine dust containing extracts of rhapis excelsa and ficus robusta | |
KR101552472B1 (en) | Method for producing Crassostrea gigas extract with increased antioxidant and whitening activity | |
KR20120117116A (en) | Cosmetic compositions for preventing skin cell death comprising extracts of fermented red ginseng | |
Song et al. | Lactobacillus plantarum fermented Laminaria japonica alleviates UVB-induced epidermal photoinflammation via the Keap-1/Nrf2 pathway | |
CN116120420A (en) | Bird's nest polypeptide composition, preparation method thereof and application thereof in anti-aging and whitening | |
KR20160008862A (en) | Composition for skin irritant alleviation, skin barrier enhancement and anti-inflammatory with the ethyl acetate extract of Rose davurica | |
KR20170062222A (en) | Composition for skin enhancement |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
A302 | Request for accelerated examination | ||
E902 | Notification of reason for refusal | ||
N231 | Notification of change of applicant | ||
E90F | Notification of reason for final refusal | ||
E801 | Decision on dismissal of amendment | ||
E90F | Notification of reason for final refusal | ||
E701 | Decision to grant or registration of patent right |